Skip to main content

Table 1 Comercial sources, clones, and working dilutions of antibodies used in this case

From: Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature

Antibody

Dilution

Clone

Vendor

HMWK

Ready to use

34 βE12

Novocastra, New Castle, UK

EMA

Ready to use

GP1.4

Novocastra, New Castle, UK

CK

Ready to use

AE1/AE3

Novocastra, New Castle, UK

CK20

Ready to use

PW31

Novocastra, New Castle, UK

CDX-2

1: 100

AMT28

Novocastra, New Castle, UK

CK7

Ready to use

RN7

Novocastra, New Castle, UK

CD5

Ready to use

4C7

Novocastra, New Castle, UK

Villin

1: 200

CWWB1

Novocastra, New Castle, UK

MOC31

1: 50

MOC31

Novocastra, New Castle, UK

ER

Ready to use

6 F11

Novocastra, New Castle, UK

PR

Ready to use

16

Novocastra, New Castle, UK

TTF-1

1: 200

SPT24

Novocastra, New Castle, UK

GCDFP-15

Ready to use

23A3

Novocastra, New Castle, UK

P63

1: 25

7JUL

Novocastra, New Castle, UK

CD30

Ready to use

JCM182

Novocastra, New Castle, UK

PLAP

Ready to use

8A9

Novocastra, New Castle, UK

Chromogranin

Ready to use

5H7

Novocastra, New Castle, UK

CD117

Ready to use

T595

Novocastra, New Castle, UK

Calretinin

1: 200

CAL6

Novocastra, New Castle, UK